Using urine tests to detect endometriosis with spectroscopy
Detection of Endometriosis Using ATR-FTIR Spectroscopy
NA · Federal University of Espirito Santo · NCT06426420
This study is testing a new way to detect endometriosis using urine samples and special technology to see if it can provide a quicker and easier diagnosis for patients.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | Female |
| Sponsor | Federal University of Espirito Santo (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Vitória, Espírito Santo) |
| Trial ID | NCT06426420 on ClinicalTrials.gov |
What this trial studies
This study aims to investigate the use of Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) spectroscopy as a non-invasive method for detecting endometriosis through urine samples. Endometriosis is a chronic condition that often goes undiagnosed due to its non-specific symptoms and the invasive nature of current diagnostic methods. By employing ATR-FTIR spectroscopy combined with machine learning algorithms, the researchers hope to develop a rapid and accurate test for endometriosis detection, potentially improving patient outcomes and treatment timelines.
Who should consider this trial
Good fit: Ideal candidates for this study are females experiencing pelvic pain who are between the ages of 18 and 55.
Not a fit: Patients outside the age range of 18 to 55 or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a quicker and less invasive method for diagnosing endometriosis, leading to earlier treatment and improved quality of life for patients.
How similar studies have performed: While the use of spectroscopy for medical diagnostics is an emerging field, this specific application for endometriosis detection is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female * Pelvic pain complain Exclusion Criteria: * Age under 18 or above 55 * Lack of informed consent
Where this trial is running
Vitória, Espírito Santo
- University Hospital Cassiano Antonio Moraes at Federal Univeristy Of Espírito Santo — Vitória, Espírito Santo, Brazil (RECRUITING)
Study contacts
- Principal investigator: Valerio G Barauna, PhD — Universidade Federal do Espírito Santo
- Study coordinator: Valerio G Barauna, PhD
- Email: barauna2@gmail.com
- Phone: +5527996892407
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Endometriosis, Endometriomas, Diagnosis, Spectroscopy, FTIR, Urine, Detection, Infrared